Real-world outcomes of Budesonide/Glycopyrronium/Formoterol therapy in COPD after 3 months; Interim analysis of the RECORD study

被引：0
|
作者：
Watz, Henrik [1 ]
Halbach, Marija [2 ]
Saathoff, Matthias [2 ]
Morris, Tamsin [3 ]
Watt, Michael [3 ]
Milano, Annika Fernandez [4 ]
Shrikrishna, Dinesh [5 ]
Singh, Dave [6 ]
机构：
[1] LungenClin Grosshansdorf, Veloc Clin Res, Pulm Res Inst, Grosshansdorf, Germany
[2] AstraZeneca GmbH, Hamburg, Germany
[3] AstraZeneca UK, London, England
[4] IQVIA Commercial GmbH & Co OHG, Frankfurt, Germany
[5] Musgrove Pk Hosp, Somerset NHS Fdn Trust, Taunton, England
[6] Univ Manchester, Manchester, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA3909
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Budesonide/Glycopyrronium/Formoterol in the real world; The RECORD Study
    Watz, Henrik
    Halbach, Marija
    Saathoff, Matthias
    Morris, Tamsin
    Watt, Michael
    Milano, Annika Fernandez
    Shrikrishna, Dinesh
    Singh, Dave
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [2] Baseline characteristics of patients with COPD treated with Budesonide/Glycopyrronium/ Formoterol in the real world; the RECORD study
    Watz, H.
    Halbach, M.
    Saathoff, M.
    Morris, T.
    Watt, M.
    Singh, D.
    PNEUMOLOGIE, 2024, 78 : S64 - S64
  • [3] Baseline characteristics of patients with COPD treated with Budesonide / Glycopyrronium / Formoterol in the real world; The RECORD Study
    Watz, Henrik
    Halbach, Marija
    Saathoff, Matthias
    Morris, Tamsin
    Watt, Michael
    Singh, Dave
    INNERE MEDIZIN, 2024, 65 : S79 - S79
  • [4] First Real-World Evidence on budesonide/glycopyrronium/formoterol fumarate (BGF) use for COPD patients in France (ENARXI study): an interim analysis
    Deslee, Gaetan
    Poccardi, Nolwenn
    Fabry-Vendrand, Caroline
    Leynaud, Delphine
    Thabut, Gabriel
    Eteve-Pitsaer, Caroline
    Coriat, Adrien
    Ghout, Idir
    Leleu, Henri
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Real-world study of formoterol/budesonide delivered through BAI in COPD patients
    Balamurugan, Santhalingam
    Pophale, Himanshu
    Samariya, Utsav
    Apte, Komalkirti
    Singh, Sheetu
    Dhar, Raja
    Rajan, Sujeet
    Swarnakar, Rajesh
    Talwar, Deepak
    Lopez, Meena
    Naik, Vaishali
    Sawant, Sandesh
    Chhowala, Sushmeeta
    Vaidya, Abhijit
    Gogtay, Jaideep
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Exacerbations and Real-world Outcomes (EROS) Among Patients With COPD Receiving Single Inhaler Triple Therapy of Budesonide/glycopyrrolate/formoterol Fumarate
    Pollack, M.
    Tkacz, J. P.
    Schinkel, J.
    Lewing, B.
    Agatep, B.
    Swisher, S.
    Patel, S.
    Edwards, D.
    Touchette, D.
    Portillo, E.
    Feigler, N.
    Strange, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [7] Characteristics of Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol or Other Triple Therapies in Japan: A Real-World Healthcare Claims Database Study (MITOS-AURA)
    Takahashi, Koichiro
    Makita, Naoyuki
    Castaneda-Sanabria, Johann
    Argoubi, Ramzi
    Nowacki, Gregoire
    Issa, Seham
    Matsumoto, Isao
    Yoshida, Yuri
    Mullerova, Hana
    ADVANCES IN THERAPY, 2024, 41 (12) : 4518 - 4536
  • [8] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
    Strange, Charlie
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel R.
    Portillo, Edward
    Feigler, Norbert
    Pollack, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2245 - 2256
  • [9] Characteristics of COPD patients initiating budesonide/glycopyrronium/formoterol (BGF) and other triple therapy in Japan: a health-care claims-based real-world database study (MITOS program)
    Takahashi, Koichiro
    Makita, Naoyuki
    Castaneda, Johann
    Argoubi, Ramzi
    Nowacki, Gregoire
    Issa, Seham
    Matsumoto, Isao
    Yoshida, Yuri
    Mullerova, Hana
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
    Strange, C.
    Tkacz, J.
    Schinkel, J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1799 - 1799
12345